Sequential mitoxantrone/prednisone followed by docetaxel/estramustine in patients with hormone refractory metastatic prostate cancer: results of a phase II study. [electronic resource]
Producer: 20050804Description: 419-24 p. digitalISSN:- 0923-7534
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Docetaxel
- Drug Administration Schedule
- Drug Resistance, Neoplasm
- Estramustine -- administration & dosage
- Humans
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Prednisone -- administration & dosage
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- drug therapy
- Survival Analysis
- Taxoids -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.